Skye Bioscience SKYE Balance Sheet (2012-2026)

NASDAQ SKYE
$0.26 -0.02 (-5.66%)
As of: Aug 21, 2026 · 9:46 AM EDT
Balance Sheet Apr2012 Jul2012 Oct2012 Jan2013 Apr2013 Jul2013 Oct2013 Dec2013 Apr2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Receivables - Affiliates (Quarter)
0.01M0.02M
Receivables - Notes (Quarter)
Assets
Current Assets
Cash & Equivalents (Quarter)
5.19M0.00M0.00M0.00M0.00M0.00M0.00M0.55M9.08M1.26M83.34M74.12M67.41M68.42M46.42M23.84M18.44M5.88M8.15M
Receivables - Net (Quarter)
Receivables - Other (Quarter)
0.01M0.02M0.01M0.05M0.05M0.05M0.01M0.05M
Receivables (Quarter)
0.05M
Prepaid Assets (Quarter)
0.26M0.32M0.06M0.82M0.87M0.14M0.78M0.96M1.06M0.87M1.12M1.51M1.10M2.65M0.20M0.58M1.26M0.90M0.85M0.23M
Current Assets (Quarter)
5.47M11.43M9.61M6.99M4.77M2.68M8.94M4.45M1.89M15.29M11.65M94.57M87.00M79.81M70.83M63.03M50.58M39.92M27.09M18.57M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)
0.02M0.08M0.09M0.08M0.07M0.09M0.09M0.08M0.06M0.06M0.04M0.04M0.05M1.52M1.43M1.30M1.17M1.03M0.90M0.76M
Other Non-Current Assets (Quarter)
0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.03M0.05M0.05M0.05M0.05M0.05M0.04M
Non-Current Assets (Quarter)
0.02M0.25M0.24M0.22M0.19M0.19M0.17M0.14M0.34M0.32M0.29M0.27M0.26M1.73M1.94M1.77M1.58M1.40M1.22M0.85M
Assets (Quarter)
5.49M11.69M9.86M7.21M4.97M2.87M9.11M4.59M2.24M15.60M11.94M94.84M87.26M81.54M72.76M64.79M52.16M41.32M28.31M19.42M
Liabilities
Current Liabilities
Accounts Payables (Quarter)
0.38M0.32M0.90M0.88M1.44M2.07M0.05M1.22M1.55M1.63M0.96M1.10M1.08M0.78M0.57M1.71M3.22M2.83M2.03M3.94M
Notes Payables (Quarter)
0.02M0.02M0.06M0.02M0.11M0.12M0.12M0.10M0.11M0.01M
Payables (Quarter)
0.40M0.34M0.96M0.89M1.55M2.19M0.17M1.33M1.66M1.64M0.96M1.10M1.08M0.78M0.57M1.71M3.22M2.83M2.03M3.94M
Accumulated Expenses (Quarter)
0.11M0.26M0.34M0.24M0.35M0.44M0.66M0.79M0.91M0.65M0.89M0.35M0.56M1.11M0.66M0.87M0.92M1.27M0.23M
Other Accumulated Expenses (Quarter)
0.38M0.10M0.80M0.85M0.92M0.99M3.18M1.18M2.07M0.65M0.85M2.22M2.37M2.64M3.35M
Short term Debt (Quarter)
0.45M0.12M0.03M6.21M6.21M6.21M4.37M4.61M6.05M1.82M1.91M1.81M2.05M0.25M
Current Leases (Quarter)
0.06M0.08M0.09M0.09M0.09M0.08M0.08M0.07M0.07M0.07M0.08M0.08M0.08M0.18M0.19M0.20M0.20M0.19M0.06M
Current Taxes (Quarter)
Current Deferred Revenue (Quarter)
Total Current Liabilities (Quarter)
1.55M0.50M3.91M4.18M5.24M6.15M12.12M9.37M9.82M13.72M13.90M15.80M14.32M5.62M4.34M5.32M8.31M8.37M8.21M10.40M
Non-Current Liabilities
Non-Current Debt (Quarter)
0.45M1.52M1.68M0.45M0.45M1.85M4.37M
Convertible Debt (Quarter)
1.22M1.37M
Non-Current Deffered Revenue (Quarter)
Preferred Stock Liabilities (Quarter)
Operating Leases (Quarter)
0.16M0.08M0.06M0.12M0.10M0.08M0.08M0.27M0.19M0.24M0.15M0.13M0.11M0.27M0.22M0.17M0.12M0.08M
Other Non-Current Liabilities (Quarter)
0.40M0.21M0.06M0.02M0.01M326.00
Total Non-Current Liabilities (Quarter)
2.82M3.21M3.93M4.22M5.26M6.15M
Total Liabilities (Quarter)
3.22M3.42M3.99M4.24M5.27M6.15M12.12M9.37M10.03M13.91M14.07M15.95M14.45M5.73M4.61M5.54M8.48M8.49M8.29M10.40M
Shareholder's Equity
Total Debt (Quarter)
0.45M1.52M2.13M0.57M0.48M8.05M6.21M6.21M8.74M4.61M6.05M1.82M1.91M1.81M2.05M0.25M
Common Equity (Quarter)
2.27M8.26M5.86M2.97M-0.30M-3.28M-3.01M-4.78M-7.79M1.70M-2.13M78.88M72.81M75.80M68.15M59.25M43.68M32.84M20.02M9.01M
Liabilities and Shareholders Equity (Quarter)
5.49M11.69M9.86M7.21M4.97M2.87M9.11M4.59M2.24M15.60M11.94M94.84M87.26M81.54M72.76M64.79M52.16M41.32M28.31M19.42M
Retained Earnings (Quarter)
-42.92M-44.74M-47.26M-50.30M-53.72M-56.85M-66.74M-71.91M-75.02M-99.96M-104.38M-109.40M-117.30M-121.20M-130.95M-142.05M-159.68M-172.43M-186.87M-199.38M
Preferred Shares (Quarter)
Treasury Shares (Quarter)
0.60M0.15M0.15M0.01M0.85M1.12M1.12M1.14M0.50M0.50M0.50M0.50M0.49M0.49M